varicellazost
viru
vzv
member
alphaherpesviru
famili
etiolog
agent
chickenpox
shingl
human
cellfre
virion
releas
skin
lesion
transmit
epitheli
cell
respiratori
tract
suscept
host
cell
cultur
howev
cellfre
infecti
virion
spontan
releas
infect
exclus
celltocel
spread
viru
cellfre
viru
obtain
sonic
infect
cell
lack
high
titer
cellfre
viru
hinder
progress
studi
defin
mechan
vzv
enter
target
cell
previou
studi
identifi
cellular
molecul
import
entri
vzv
cell
cationindepend
mannos
receptor
mprci
propos
facilit
earli
step
vzv
infect
previou
studi
laboratori
show
insulindegrad
enzym
ide
member
zinc
metalloproteinas
famili
put
cellular
receptor
vzv
downregul
ide
specif
sirna
inhibit
ide
activ
bacitracin
block
ide
antibodi
inhibit
vzv
infect
impair
celltocel
spread
viru
overexpress
human
ide
transfect
cell
line
result
increas
entri
cellfre
cellassoci
viru
vzv
glycoprotein
e
ge
essenti
viru
infect
interact
ide
bind
domain
locat
amino
terminu
ectodomain
ge
conserv
human
herpesvirus
vzv
delet
ide
bind
domain
ge
impair
infect
cellfre
viru
show
reduc
celltocel
spread
viru
vitro
human
skin
xenograft
scid
mice
show
interact
ide
ge
import
vzvinduc
syncytia
format
fusogen
recombin
solubl
ide
ride
modifi
ge
induc
conform
chang
ge
enhanc
vzv
infect
stabil
cellfre
viru
open
read
frame
human
ide
contain
two
atg
near
amino
terminu
could
serv
translat
initi
codon
previou
studi
clone
ide
cdna
show
second
atg
encod
amino
acid
better
match
kozak
consensu
sequenc
serv
canon
start
site
translat
recombin
baculoviru
construct
express
human
ide
hemaglutinin
ha
tag
insert
second
methionin
amino
acid
ide
driven
polyhedrin
promot
fig
ride
express
kd
protein
fig
although
gel
filtrat
show
oligomer
protein
report
previous
incub
ride
radiolabel
insulin
result
similar
profil
degrad
product
seen
endogen
ide
rat
liver
anoth
form
recombin
ide
fig
ride
insulin
degrad
activ
similar
recombin
fig
previous
show
ide
interact
extracellular
domain
vzv
ge
ge
mutant
lack
amino
acid
bind
ide
ge
mutant
lack
amino
acid
unabl
bind
vzv
gi
show
enhanc
bind
ide
found
ride
also
form
complex
extracellular
domain
ge
ride
interact
ge
lack
ide
bind
domain
ride
interact
greater
extent
mutant
ge
bind
gi
fig
previous
report
purifi
endogen
ide
protein
extract
liver
block
vzv
infect
ride
clone
cdna
express
baculovirusinfect
cell
enhanc
vzv
infect
differ
activ
two
protein
could
due
differ
amino
termini
ride
begin
canon
initi
codon
amino
acid
purifi
ride
show
singl
band
kd
nativ
ide
purifi
liver
actual
complex
mixtur
ide
form
investig
effect
ride
vzv
infect
incub
cellfre
vzv
rokalacz
ride
control
protein
min
infect
human
melanoma
cell
viru
three
day
later
cell
fix
treat
xgal
blue
foci
count
ride
significantli
enhanc
vzv
infect
compar
control
protein
spgc
buffer
alon
p
ride
vs
control
protein
student
test
fig
enhanc
infect
observ
ride
ad
hr
postinfect
bypass
entri
step
p
ride
ad
min
infect
vs
ride
ad
hr
infect
student
test
fig
denatur
ride
mm
citric
acid
ph
follow
neutral
hepe
buffer
ph
final
ph
inactiv
enhanc
activ
ide
result
indic
nativ
form
ride
requir
enhanc
infect
ride
function
earli
stage
infect
incub
ride
cellfre
vzv
min
ad
viru
cell
enhanc
infect
dosedepend
manner
p
anova
fig
sinc
vzv
highli
cellassoci
vitro
cellfre
viru
produc
sonic
labil
infect
declin
quickli
time
test
whether
incub
cellfre
vzv
ride
enhanc
stabil
viru
ride
increas
viru
infect
incub
cellfre
rokalacz
hr
compar
buffer
filtrat
pass
ride
purif
fig
ride
also
enhanc
cellfre
vzv
infect
andor
stabil
incub
hr
prior
infect
cell
p
ride
vs
buffer
control
student
test
fig
last
two
column
fig
enhanc
viru
stabil
incub
ride
vzv
observ
rang
incub
period
room
temperatur
fig
p
ride
vs
bsa
control
combin
data
experi
replic
incub
ride
cellfre
viru
min
infect
cell
also
augment
vzv
infect
fig
result
indic
ride
enhanc
infect
stabil
cellfre
vzv
wide
rang
incub
time
incub
temperatur
determin
effect
ride
vzv
infect
earli
step
viru
infect
perform
quantit
pcr
vzv
dna
determin
copi
number
viral
genom
insid
cell
min
infect
incub
ride
viru
prior
infect
result
increas
number
vzv
genom
insid
cell
compar
viru
incub
control
protein
indic
ride
increas
viru
intern
p
ride
vs
fig
addit
ride
hr
infect
vzv
result
increas
size
plaqu
p
ride
vs
bsa
control
ride
vs
buffer
fig
suggest
ride
augment
infect
cellfre
viru
entri
also
promot
infect
enhanc
celltocel
spread
viru
consist
earlier
observ
ide
import
infect
cellfre
cellassoci
vzv
sinc
prior
experi
perform
use
recombinantderiv
vzv
also
test
effect
ride
nonrecombin
virus
cellfre
zoster
vaccin
viru
contain
variou
stabil
reconstitut
accord
manufactur
instruct
incub
ride
control
protein
min
ride
increas
infect
zoster
vaccin
viru
p
ride
vs
buffer
bovin
serum
albumen
bsa
control
protein
student
test
fig
ide
metalloproteinas
ide
interact
varieti
substrat
cleav
subset
substrat
insulin
protein
percept
rate
previous
incub
extracellular
domain
ge
get
ide
protein
extract
liver
detect
cleavag
degrad
get
use
monoclon
antibodi
determin
ride
modifi
ge
incub
biotinlabel
get
protein
ride
control
protein
encod
vaccinia
viru
protein
encod
epsteinbarr
viru
protein
min
protein
boil
sampl
buffer
separ
sdspage
gel
get
stain
streptavidin
conjugatedhors
radish
peroxidas
incub
get
ride
control
protein
result
slightli
smaller
size
band
full
length
get
indic
ride
modifi
get
fig
somewhat
surpris
ride
modifi
ge
incub
consist
observ
ride
enhanc
vzv
infect
fig
mani
viral
glycoprotein
undergo
conform
chang
bind
receptor
coreceptor
result
exposur
fusion
peptid
embed
viral
glycoprotein
initi
seri
event
lead
fusion
viral
envelop
cell
membran
sinc
vzv
ge
import
role
syncytia
format
membran
fusion
postul
ge
might
undergo
conform
chang
bind
ride
limit
exposur
ligandreceptor
complex
proteinas
use
detect
receptorinduc
conform
chang
sever
protein
includ
avian
sarcomaleucosi
viru
alv
envelop
protein
complex
receptor
tva
spike
protein
mous
hepat
viru
complex
solubl
receptor
extracellular
domain
ge
label
biotin
incub
ride
buffer
control
protein
room
temperatur
min
follow
addit
thermolysin
proteinas
hydrolyz
peptid
bond
hydrophob
residu
sec
protein
separ
sdspage
gel
incub
streptavidin
conjugatedhors
radish
peroxidas
incub
get
ride
buffer
control
protein
result
reduct
intens
kda
get
band
fig
similar
result
also
observ
endoproteinas
aspn
digest
fig
therefor
ride
trigger
conform
chang
vzv
get
confer
increas
suscept
proteinas
repeat
attempt
determin
cleavag
site
ge
ntermin
protein
sequenc
fail
gener
sequenc
glutam
acid
zincbind
site
human
ide
major
catalyt
residu
insulin
degrad
function
mutat
glutam
acid
glutamin
ide
result
mutant
protein
catalyt
inact
insulin
degrad
although
form
complex
get
fig
fail
elicit
conform
chang
get
compar
ride
wildtyp
ide
thermolysin
assay
fig
e
result
suggest
catalyt
activ
ide
insulin
degrad
might
import
induc
conform
chang
ge
determin
interact
ge
ide
import
membran
fusion
use
report
system
vzv
permiss
hela
cell
transfect
plasmid
encod
promot
serv
target
cell
one
day
transfect
target
cell
incub
hr
melanoma
cell
stabli
express
polymeras
contain
equal
titer
pfuml
control
vzv
roka
mutant
viru
lack
ide
bind
domain
amino
acid
ge
incub
target
cell
cell
result
reduc
membran
fusion
activ
measur
lower
level
compar
rokainfect
cell
p
roka
vs
student
test
fig
similar
result
observ
also
express
gfp
rokagfp
fig
transfect
hela
cell
vector
control
plasmid
place
report
plasmid
follow
infect
vzv
roka
result
background
level
fusion
activ
therefor
vzv
mutant
lack
ide
bind
domain
ge
reduc
membran
fusogen
examin
function
ide
vzv
infect
analyz
syncyctia
format
cell
infect
truncat
ge
viru
impair
bind
ide
pulldown
assay
mutant
viru
impair
matur
egress
cell
surfac
show
smaller
syncytia
fewer
nuclei
syncytia
compar
parent
virus
roka
rokagfp
fig
b
cell
infect
significantli
fewer
nuclei
per
syncytium
cell
infect
rokagfp
total
number
nuclei
syncytia
quantifi
use
dimension
reconstruct
sequenti
zsection
cell
confoc
microscopi
fig
p
rule
possibl
reduc
level
syncytia
format
vzv
mutant
might
due
defect
matur
transport
cell
surfac
andor
cellcel
junction
perform
immunoelectron
microscopi
studi
melanoma
cell
infect
show
larg
number
envelop
virion
accumul
cellcel
junction
fig
cell
surfac
fig
randomli
select
immuneelectron
micrograph
total
geposit
virion
cell
surfac
andor
cell
junction
compar
total
geposit
roka
virion
pictur
fig
p
vs
roka
indic
impair
syncytia
format
celltocel
spread
ide
bind
domain
mutant
viru
due
defect
matur
reduc
transport
cell
surfac
cellcel
junction
previou
studi
show
vzv
ge
myristyl
myristyl
protein
import
associ
membran
rule
possibl
delet
ide
bind
domain
ge
advers
affect
ge
myristyl
label
roka
infect
cell
acid
immunoprecipit
ge
ge
parent
mutant
vzv
show
similar
level
myristyl
indic
differ
myristyl
explain
phenotyp
observ
mutant
viru
fig
therefor
ide
bind
domain
ge
import
membran
fusogen
syncytia
format
celltocel
spread
viru
shown
solubl
ride
enhanc
vzv
infect
celltocel
spread
human
melanoma
cell
earli
step
viru
infect
ride
interact
ge
elicit
conform
chang
ge
modifi
size
ge
addit
vzv
mutant
viru
lack
ide
bind
domain
ge
impair
syncytia
format
membran
fusion
suggest
ide
enhanc
infect
stabil
viru
elicit
conform
chang
ge
modul
fusogen
vzv
infect
previou
studi
use
fibroblast
melanoma
cell
suggest
ide
function
cellular
receptor
ge
enhanc
vzv
infect
celltocel
spread
two
cell
type
howev
recent
studi
found
although
vzv
mutant
delet
ide
bind
domain
ge
show
reduc
celltocel
spread
viru
melanoma
cell
impair
infect
skin
xenograft
vivo
defect
infect
cell
suggest
ide
may
facilit
viru
entri
celltyp
depend
manner
similar
epsteinbarr
viru
close
relat
herp
simplex
viru
hsv
cellular
molecul
also
shown
preferenti
mediat
viru
entri
differ
cell
type
import
entri
hsv
neuron
hvem
use
entri
lymphocyt
vzv
ge
bind
ide
aminotermin
region
although
overal
conform
ge
import
interact
ide
observ
ge
produc
baculoviru
express
system
smaller
size
counterpart
produc
mammalian
cell
li
et
al
unpublish
data
suggest
less
glycosyl
insect
cell
ge
produc
baculoviru
form
complex
ide
impli
glycosyl
ge
may
import
interact
ide
carpent
et
al
report
ide
bind
matur
form
vzv
ge
low
salt
condit
ide
bind
kda
form
ge
high
salt
condit
show
tunicamycin
block
glycosyl
ge
endoplasm
reticulum
result
product
kda
form
ge
presenc
tunicamycin
ge
block
transit
endoplasm
reticulum
therefor
conclud
ide
must
interact
kda
form
ge
cytosol
bind
repres
receptorligand
interact
interestingli
previou
studi
author
show
smaller
form
ge
present
cell
surfac
recycl
endocytot
pathway
incorpor
virion
studi
group
also
show
mixtur
form
ge
rang
kda
present
purifi
virion
therefor
kda
form
ge
present
virion
may
interact
ide
solubl
receptormedi
enhanc
viru
infect
report
sever
virus
includ
hiv
avian
leukosissarcoma
viru
mous
coronaviru
close
relat
herp
simplex
viru
hsv
heparan
sulfat
function
receptor
hsv
solubl
heparin
sulfat
trigger
hsv
entri
nonpermiss
cell
augment
viral
glycoproteinmedi
membran
fusion
solubl
truncat
form
lack
transmembran
domain
confer
hsv
suscept
nonpermiss
cell
studi
show
solubl
v
domain
amino
acid
residu
promot
hsv
entri
interestingli
studi
neither
free
gdbound
bound
cell
surfac
suggest
interact
solubl
receptor
gd
ligand
facilit
viru
penetr
activ
viral
fusion
machineri
rather
directli
enhanc
viru
attach
cell
ride
increas
vzv
infect
earli
stage
infect
treatment
radiolabel
vzv
ride
enhanc
viru
bind
fig
thu
solubl
ride
appear
promot
vzv
infect
increas
effici
entri
viru
cell
rather
enhanc
attach
conclus
support
observ
ride
increas
intern
vzv
dna
within
min
initi
infect
found
ride
induc
conform
chang
vzv
ge
numer
studi
establish
receptor
bindinginduc
conform
chang
viral
glycoprotein
critic
initi
virusmedi
membran
fusion
conform
chang
result
expos
viral
fusion
peptid
provid
energi
fusion
process
refold
larger
virus
hsv
fusion
machineri
consist
one
glycoprotein
work
concert
sinc
vzv
ge
fusogen
express
alon
act
fusogen
concert
glycoprotein
possibl
conform
chang
elicit
ride
may
either
directli
enhanc
fusogen
ge
allow
recruit
glycoprotein
gb
gh
form
fusion
complex
addit
receptorbind
mediat
conform
chang
viral
glycoprotein
sequenti
conform
chang
induc
proteolysi
requir
entri
process
sever
virus
proteas
cleav
viral
fusion
protein
includ
glycoprotein
matur
fusogen
form
enhanc
viru
bind
infect
find
ride
metalloproteinas
trigger
conform
chang
ge
modifi
size
ge
suggest
proteolyt
activ
ide
might
import
vzv
infect
support
fact
ide
mutant
impair
degrad
insulin
fail
induc
conform
chang
ge
sinc
ge
much
larger
insulin
ge
lack
detect
amino
acid
homolog
substrat
ide
interact
amino
acid
residu
ide
insulin
ge
like
differ
therefor
may
proteolyt
motif
ide
ge
differ
degrad
insulin
hsv
enter
cell
differ
pathway
involv
either
cell
surfac
membran
intracellular
vesicl
endosom
celltyp
depend
manner
previou
work
hambleton
colleagu
suggest
vzv
enter
human
fibroblast
endocytosi
pathway
although
shown
ride
enhanc
vzv
intern
clear
whether
occur
cell
surfac
endosom
cell
type
endogen
ide
local
primarili
endosom
subcellular
compart
cell
surfac
extracellular
space
interest
note
upon
receptor
bind
activ
coronaviru
glycoprotein
extracellular
proteas
facilit
viru
entri
cell
surfac
plasma
membran
absenc
extracellular
proteas
viru
enter
cell
use
endosom
pathway
found
ride
increas
stabil
cellfre
vzv
two
possibl
explan
ride
might
enhanc
viru
stabil
first
interact
viru
glycoprotein
receptor
may
convert
glycoprotein
nativ
state
new
metast
state
result
longliv
envelop
proteinreceptor
intermedi
alv
preload
form
solubl
receptor
tvatvb
stabl
second
pretreat
viru
receptor
may
target
viru
enter
cell
pathway
favor
infect
alv
bound
glycophosphatidylinositolanchor
form
receptor
tva
accumul
fusion
compart
stabl
enter
though
transmembraneanchor
form
receptor
although
endogen
ide
found
cell
surfac
endosom
contain
predict
membran
anchor
domain
postul
howev
ide
might
contain
glycophosphatidylinositol
anchor
cellfre
vzv
usual
produc
vitro
sonic
infect
cell
viru
labil
current
varicella
zoster
vaccin
use
unit
state
suppli
lyophil
virus
must
store
colder
use
within
minut
reconstitut
aqueou
solut
ride
might
use
addit
cellfre
vzv
vaccin
improv
stabil
found
vzv
lack
ide
bind
domain
ge
impair
virusinduc
membran
fusion
syncytia
format
celltocel
spread
even
though
geposit
virion
accumul
cell
surfac
cell
junction
transmiss
vzv
vitro
occur
exclus
celltocel
spread
grose
colleagu
postul
vzv
evolv
viral
glycoprotein
gear
toward
celltocel
fusion
mediat
syncytia
format
rather
toward
virustocel
fusion
seen
hsv
sever
studi
suggest
ge
import
role
virusinduc
membran
fusion
infect
ge
promot
fusion
coexpress
either
gb
gh
transfect
cell
use
vaccinia
viru
express
system
berarducci
et
al
describ
vzv
mutant
delet
part
ide
bind
domain
ge
show
reduc
celltocel
spread
find
vzv
mutant
delet
ide
bind
domain
impair
syncytia
format
membran
fusion
provid
evid
role
ge
receptor
bind
molecul
contributor
fusogen
propos
interact
ide
ge
result
receptor
bind
conform
chang
may
includ
proteolysi
process
would
lead
enhanc
fusogen
either
alon
conjunct
recruit
viral
glycoprotein
entri
vzv
target
cell
human
melanoma
cell
mewo
charl
grose
univers
iowa
fibroblast
cell
american
type
cultur
collect
manassa
va
grown
minimum
essenti
medium
fetal
bovin
serum
fb
hela
cell
american
type
cultur
collect
maintain
dulbecco
modifi
eagl
medium
fb
spodoptera
frugiperda
insect
cell
cultur
tnmfh
medium
bd
bioscienc
pharmingen
san
diego
ca
vzv
strain
roka
recombin
deriv
oka
rokalacz
roka
express
betagalactosidas
rokagfp
vzv
mutant
grown
mewo
cell
construct
insert
cassett
contain
human
cytomegaloviru
promot
drive
green
fluoresc
protein
gfp
plasmid
clontechbd
bioscienc
palo
alto
ca
avrii
site
cosmid
vzv
locat
vzv
result
cosmid
tranfect
melanoma
cell
along
plasmid
cosmid
noti
ib
mst
iib
viru
obtain
term
cellfre
vzv
viru
prepar
vzvinfect
cell
display
cytopath
effect
cpe
scrape
cell
flask
spgc
buffer
fb
sodium
glutamin
sucros
pb
freezethaw
cell
sonic
lysat
centrifug
lysat
min
transfer
supernat
new
tube
viru
stock
cellfre
zoster
vaccin
zostavax
merck
whitehous
station
nj
reconstitut
steril
water
follow
manufactur
instruct
use
experi
cellfre
vzv
viru
encod
gfp
incub
ride
protein
ad
mewo
cell
spgc
buffer
min
chang
normal
growth
medium
infect
foci
score
day
postinfect
stain
xgal
cellfre
vaccin
viru
reconstitut
steril
water
recommend
manufactur
ad
mewo
cell
describ
four
day
infect
cell
fix
stain
antig
monoclon
antibodi
chemicon
temecula
ca
follow
antimousealexa
secondari
antibodi
invitrogen
carlsbad
ca
infect
foci
visual
fluoresc
microscopi
construct
recombin
baculoviru
express
hatag
human
ide
ride
report
elsewher
use
infect
insect
cell
three
day
postinfect
cell
collect
treat
lysi
buffer
mm
trishcl
ph
mm
edta
mm
nacl
lysat
centrifug
g
min
hatag
ride
purifi
clear
supernat
antiha
conjug
affin
column
sigma
st
loui
mo
extens
wash
pb
ride
elut
ha
peptid
pb
excess
ha
peptid
remov
use
centriprep
column
kda
molecular
weight
cutoff
millipor
billerica
experi
haid
purifi
gel
filtrat
column
mm
tri
ph
mm
nacl
buffer
express
purif
polyhistidinetag
human
wildtyp
idewt
mutant
ide
protein
e
coli
perform
previous
describ
minor
modif
briefli
plasmid
pproexidewt
propag
e
coli
rosetta
cell
protein
express
induc
final
concentr
hr
cell
lyse
ripa
buffer
mm
trishcl
ph
mm
nacl
mm
edta
deoxychol
acid
sd
polyhistidinetag
ide
purifi
talon
metal
affin
column
clontech
mountain
view
ca
elut
mm
imidazol
dialyz
overnight
pb
insect
cell
infect
recombin
baculoviru
express
extracellular
domain
vzv
ge
ctermin
histidin
tag
three
day
infect
tissu
cultur
supernat
harvest
get
protein
purifi
talon
metal
affin
column
clontech
mountain
view
ca
extens
wash
mm
imidazol
dilut
pb
pb
buffer
alon
mgml
ezlink
sulfonhsbiotin
pb
ph
pierc
rockford
il
ad
resin
incub
min
follow
three
wash
cold
pb
biotinyl
protein
elut
mm
imidazol
dialyz
overnight
pb
gefc
control
vaccinia
ebv
fc
fusion
protein
describ
previous
serial
dilut
fc
fusion
protein
coat
onto
elisa
plate
overnight
wash
pb
contain
antihuman
fchorseradish
peroxidas
ad
pierc
rockford
il
amount
fc
fusion
protein
design
specif
fc
unit
measur
spectrophotometr
nm
ad
substratechromogen
tmb
dakocytom
carpinteria
ca
ride
coat
onto
elisa
plate
ngwell
overnight
wash
pb
contain
block
bsa
fc
fusion
protein
ad
specif
unit
see
room
temperatur
min
allow
bind
follow
addit
antihuman
fchors
radish
peroxidas
tmb
substrat
ride
purifi
baculovirusinfect
cell
use
antiha
affin
column
elut
ha
peptid
ide
rat
liver
purifi
multipl
chromatograph
step
describ
previous
recombin
human
ide
contain
hexahistidin
flag
epitop
fuse
amino
terminu
ide
express
cell
purifi
use
cobalt
affin
chromatographi
protein
concentr
determin
use
bca
protein
assay
kit
pierc
rockford
il
degrad
assay
sampl
ide
incub
insulin
min
ide
prepar
dilut
attain
equal
level
insulin
degrad
sampl
resolv
reversephas
chromatographi
use
column
describ
previous
fraction
collect
radioact
count
degre
insulin
degrad
defin
proport
remain
intact
insulin
total
recov
radioact
pmole
insulin
degrad
sampl
calcul
specif
activ
insulin
mewo
cell
infect
cellassoci
vzv
roka
hr
label
myrist
acid
perkinelm
waltham
hr
lyse
ripa
buffer
vzv
ge
immunoprecipit
ge
monoclon
antibodi
chemicon
temecula
ca
protein
asepharos
bead
sigmaaldrich
st
loui
mo
separ
sdspage
gel
invitrogen
carlsbad
ca
gel
incub
h
enhanc
perkinelm
waltham
accord
manufactur
instruct
autoradiographi
human
melanoma
cell
seed
thermanox
coverslip
nalg
nunc
intern
rochest
ny
infect
cellassoci
vzv
parent
viru
roka
similar
cpe
note
cell
fix
paraformaldehyd
electron
microscopi
scienc
hatfield
pa
ice
min
coverslip
incub
milk
stain
antig
antibodi
millipor
billerica
fluoronanogold
conjugatedantimous
nanoprob
yaphank
ny
follow
final
fixat
paraformaldehyd
glutaraldehyd
sodium
cacodyl
buffer
overnight
sampl
wash
three
time
distil
water
follow
sodium
citrat
silver
enhanc
min
hq
silver
reagent
nanoprob
yaphank
ny
sampl
postfix
osmium
potassium
ferrocyanid
sodium
cacodyl
dehydr
grade
ethanol
seri
embed
spurr
resin
thin
section
cut
rmc
ultramicrotom
ventana
tucson
az
stain
uranyl
acet
prior
view
kv
hitachi
transmiss
electron
microscop
hitachi
tokyo
japan
digit
imag
acquir
hammamatsu
bottom
mount
digit
camera
system
advanc
microscopi
techniqu
danver
process
use
adob
photoshop
v
adob
system
inc
san
jose
ca
vzv
intern
assay
modifi
previou
protocol
use
determin
intern
kaposi
sarcomaassoci
herpesviru
cellfre
vzv
prepar
filter
nonpyrogen
filter
pall
corpor
cornwal
uk
ad
mewo
cell
seed
plate
spgc
buffer
ice
min
allow
bind
cell
entri
initi
rais
incub
temperatur
indic
time
extracellular
viru
remov
treat
cell
heparin
pb
ice
min
wash
pb
inactiv
viru
low
ph
nacitr
buffer
mm
sodium
citrat
mm
kcl
mm
nacl
ph
room
temperatur
min
wash
pb
extracellular
vzv
viral
dna
remov
incub
cell
proteinas
k
hbss
buffer
invitrogen
carlsbad
ca
mm
room
temperatur
min
wash
pb
ad
unit
dnase
per
sampl
room
temperatur
min
roch
appli
scienc
indianapoli
intracellular
vzv
viral
dna
extract
togeth
cellular
genom
dna
use
dneasi
blood
tissu
kit
qiagen
valencia
ca
follow
manufactur
protocol
copi
number
intracellular
vzv
genom
dna
determin
realtim
pcr
use
primer
probe
target
vzv
describ
previous
serial
dilut
plasmid
use
gener
standard
curv
copi
number
vzv
genom
dna
normal
use
copi
number
human
rnasep
dna
amplifi
sampl
effect
heparin
treatment
acid
inactiv
remov
unintern
viru
proteinas
k
follow
dnase
digest
remov
extracellular
viral
dna
verifi
quantit
pcr
dna
extract
virusbound
cell
viru
bind
ice
minut
without
shift
puls
proteolysi
get
perform
follow
modif
biotinyl
get
protein
incub
ride
control
protein
room
temperatur
min
follow
ad
equal
volum
urea
hr
room
temperatur
thermolysin
dilut
buffer
nacl
mm
ad
room
temperatur
sec
digest
termin
ad
edta
sampl
boil
sdspage
gel
load
buffer
separ
electrophoresi
protein
fragment
detect
streptavidin
conjugatedhors
radish
peroxidas
membran
fusion
assay
use
report
adapt
feng
et
al
plasmid
encod
promot
gift
ed
berger
niaid
nih
bethesda
md
plasmid
encod
polymeras
driven
earli
promot
kindli
suppli
william
studier
brookhaven
nation
laboratori
upton
new
york
mewo
cell
stabli
express
polymeras
gener
cotransfect
pcineo
promega
madison
wi
follow
neomycin
select
mgml
vzv
roka
propag
titrat
equival
pfu
plaqu
form
unit
mewo
cell
express
polymeras
serv
effect
cell
vzv
permiss
hela
cell
transfect
hr
serv
target
cell
effect
cell
vzvinfect
mewo
cell
express
polymeras
mix
target
cell
hela
cell
gene
driven
promot
hr
cell
lyse
pb
contain
galactosidas
express
result
fusion
effect
target
cell
measur
incub
lysat
chlorophenol
roch
appli
scienc
indianapoli
perform
spectrophotometri
nm
